Search research articles
Contact Us
Filters
Showing results (41-50 of 58) with videos related to
Page
of 6
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
October 20, 2025
Real-world lecanemab adoption in Japan 1 year after launch: Insights from 311 specialists on infrastructure and reimbursement barriers
Kenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
The Journal of Prevention of Alzheimer'S Disease
|
April 12, 2026
ATNIVS biomarker heterogeneity in real-world patients receiving lecanemab
Masanori Kurihara, Ryoko Ihara, Gen Yoshii, et al.
Scientific Reports
|
July 27, 2023
High sensitivity of asymmetric <sup>18</sup>F-THK5351 PET abnormality in patients with corticobasal syndrome
Masanori Kurihara, Kenji Ishibashi, Tomoyasu Matsubara, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
June 8, 2026
Clinical and MRI features associated with amyloid positivity in secondary screening for anti-amyloid-β therapy
Kazuki Yamada, Masanori Kurihara, Yusuke Akitomi, et al.
Neuroimage. Clinical
|
August 11, 2019
Visualizing modules of coordinated structural brain atrophy during the course of conversion to Alzheimer's disease by applying methodology from gene co-expression analysis
Kenichiro Sato, Tatsuo Mano, Hiroshi Matsuda, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
March 4, 2023
Correlations between cerebrospinal fluid homovanillic acid and dopamine transporter SPECT in degenerative parkinsonian syndromes
Ryoji Goto, Masanori Kurihara, Masashi Kameyama, et al.
Journal of Alzheimer'S Disease : JAD
|
March 1, 2019
Lower Serum Calcium as a Potentially Associated Factor for Conversion of Mild Cognitive Impairment to Early Alzheimer's Disease in the Japanese Alzheimer's Disease Neuroimaging Initiative
Kenichiro Sato, Tatsuo Mano, Ryoko Ihara, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
March 29, 2021
Predicting amyloid risk by machine learning algorithms based on the A4 screen data: Application to the Japanese Trial-Ready Cohort study
Kenichiro Sato, Ryoko Ihara, Kazushi Suzuki, et al.
British Journal of Clinical Pharmacology
|
December 23, 2022
A first-in-human study of the anti-inflammatory profibrinolytic TMS-007, an SMTP family triprenyl phenol
Takashi Moritoyo, Naoko Nishimura, Keiko Hasegawa, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
December 22, 2025
Immediate reactions to amyloid PET disclosure in Japanese older adults without dementia
Kenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 58) with videos related to
Sort By:
Page
of 6
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
October 20, 2025
Real-world lecanemab adoption in Japan 1 year after launch: Insights from 311 specialists on infrastructure and reimbursement barriers
Kenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
The Journal of Prevention of Alzheimer'S Disease
|
April 12, 2026
ATNIVS biomarker heterogeneity in real-world patients receiving lecanemab
Masanori Kurihara, Ryoko Ihara, Gen Yoshii, et al.
Scientific Reports
|
July 27, 2023
High sensitivity of asymmetric <sup>18</sup>F-THK5351 PET abnormality in patients with corticobasal syndrome
Masanori Kurihara, Kenji Ishibashi, Tomoyasu Matsubara, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
June 8, 2026
Clinical and MRI features associated with amyloid positivity in secondary screening for anti-amyloid-β therapy
Kazuki Yamada, Masanori Kurihara, Yusuke Akitomi, et al.
Neuroimage. Clinical
|
August 11, 2019
Visualizing modules of coordinated structural brain atrophy during the course of conversion to Alzheimer's disease by applying methodology from gene co-expression analysis
Kenichiro Sato, Tatsuo Mano, Hiroshi Matsuda, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
March 4, 2023
Correlations between cerebrospinal fluid homovanillic acid and dopamine transporter SPECT in degenerative parkinsonian syndromes
Ryoji Goto, Masanori Kurihara, Masashi Kameyama, et al.
Journal of Alzheimer'S Disease : JAD
|
March 1, 2019
Lower Serum Calcium as a Potentially Associated Factor for Conversion of Mild Cognitive Impairment to Early Alzheimer's Disease in the Japanese Alzheimer's Disease Neuroimaging Initiative
Kenichiro Sato, Tatsuo Mano, Ryoko Ihara, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
March 29, 2021
Predicting amyloid risk by machine learning algorithms based on the A4 screen data: Application to the Japanese Trial-Ready Cohort study
Kenichiro Sato, Ryoko Ihara, Kazushi Suzuki, et al.
British Journal of Clinical Pharmacology
|
December 23, 2022
A first-in-human study of the anti-inflammatory profibrinolytic TMS-007, an SMTP family triprenyl phenol
Takashi Moritoyo, Naoko Nishimura, Keiko Hasegawa, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
December 22, 2025
Immediate reactions to amyloid PET disclosure in Japanese older adults without dementia
Kenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
Page
of 6